a2 Milk Company Revises Outlook Due to Supply Chain Disruptions, Shares Drop 15%

Deep News
04/14

Supply chain challenges are beginning to impact earnings guidance, with The A2 Milk Co Ltd. (ACOPY) adjusting its forecasts as disruptions affect its operations in China. The company has lowered its revenue and profit outlook, citing shipment delays partly linked to Middle East conflicts that have reduced product availability for distributors and retail outlets. Management described the issue as temporary but noted that supply gaps for infant formula with Chinese labels are already affecting market availability, just as the company was poised to continue gaining market share.

Multiple points in the supply chain appear to be under strain. Air freight availability and costs have been indirectly affected by tensions in the Middle East, while sea freight capacity remains uneven. At the same time, upstream production is tightening, with unfinished purchase orders accumulating at the Synlait Milk processing facility, and additional inspection measures prolonging product release and customs clearance times. Management indicated that these factors could substantially impact product supply in April and May, potentially dragging on sales. They also expect to incur one-time logistics costs and see some cash receipts delayed until the 2026–27 fiscal year due to postponed fourth-quarter sales.

Investors reacted swiftly, sending the company’s shares down 15% in Wellington trading, marking the largest single-day decline since August 2024. The updated guidance projects revenue growth for the fiscal year ending June 2026 in the low to mid-double-digit range, down from a prior expectation of mid-double-digit growth. Operating profit margins are also expected to decline, with net profit likely to remain flat compared to the previous year rather than improve. This revision is particularly notable given earlier market expectations that A2 Milk could capture additional market share following product recalls affecting competitors, including issues identified at Nestlé. If these supply constraints persist, discussions may resurface about the need to establish production closer to China to support more stable growth.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10